Lynne Lederman

New York

Medical, Health, and Science Writer at Freelance

medical, health, science, and mystery writer; award-winning print-maker of reduction linocuts and photolithographs

Featured in: Favicon

genengnews.com Favicon

targetedonc.com Favicon

oncnursingnews.com Favicon

obroncology.com Favicon

doximity.com Favicon

opmed.doximity.com

Articles

What Doctors Need to Understand About Disability Insurance

Feb 5, 2024 | opmed.doximity.com | Adam Rosen |Melissa Schiffman |Kevin Ladin |Lynne Lederman

Becoming a doctor is an investment. You invest time and money with the expectation that you will make a good salary to pay off any debt you have incurred in the process and with the knowledge that you will be able to live a comfortable lifestyle. For most of us during school and training, we are young, healthy, and we feel invincible.
It’s the Era of Seniors, and Our Patients Deserve Better

Feb 5, 2024 | opmed.doximity.com | Melissa Schiffman |Kevin Ladin |Lynne Lederman |Giulia Faison

This fall, ABC aired a senior version of its long-running dating reality show The Bachelor. Twenty-two women between the ages of 60 and 75 would vie to win the “final rose” and possibly a marriage proposal from the 72-year-old leading man. The entertainment media was abuzz with questions: Would viewers watch the courtship of people in their 60s and 70s? Would they be turned off by all the gray hair and walkers?
The Consequences of Our War On Opioids

Feb 5, 2024 | opmed.doximity.com | Kevin Ladin |Lynne Lederman |Giulia Faison |Forrest Bohler

The Consequences of Our War On OpioidsAs a board-certified specialist in both pain medicine and addiction medicine, I am deeply disturbed by the promulgation of misleading statistics by self-proclaimed experts and agencies such as the CDC and VA, and I am concerned about the effects that their actions are having on many of my patients struggling with chronic pain.
Urothelial Carcinoma Drug Shortages: Insights from ASCO GU

Feb 5, 2024 | opmed.doximity.com | Lynne Lederman |Giulia Faison |Forrest Bohler

Reasons behind and ways to overcome drug shortages for urothelial carcinoma were addressed at the ASCO GU Symposium. Elizabeth Guancial, MD, discussed her community practice’s approach to platinum shortages in the US during 2023.
I Competed with My Best Friend in Medical School. It Was My Worst Nightmare

Jan 29, 2024 | opmed.doximity.com | Arthur Lazarus |Drew Remignanti |Kamran Ayub |Lynne Lederman

In theory, entering medical school with a good friend should be a unique and enriching experience. Friends can become study partners, expand each other’s networks, and explore the same paths in terms of clinical rotations, research, and eventual career choices.
When Health Care Becomes Tied Up In the Bottom Line

Jan 29, 2024 | opmed.doximity.com | Drew Remignanti |Arthur Lazarus |Kamran Ayub |Lynne Lederman

When Health Care Becomes Tied Up In the Bottom Line"People need primary care but not necessarily a physician relationship," said the CEO of a multibillion dollar health care system, with 30 years of experience in health care, when asked, "What's one conviction in health care that needs to be challenged?"As a physician and patient, I find this stunningly insulting and downright dangerous to hear, especially from someone with a significant influence on the future direction of U.S. health care.
Navigating a Specialty Conference: A Comprehensive Guide

Jan 29, 2024 | opmed.doximity.com | Kamran Ayub |Lynne Lederman |Amit Phull

Specialty conferences provide invaluable opportunities for learning, networking, and staying current with advancements in the field. Here's a guide to attending these conferences successfully, divided into five key subsections:1.
Addressing the Challenges of Young-Onset Colorectal Cancer

Jan 29, 2024 | opmed.doximity.com | Lynne Lederman |Amit Phull |Hailey Roumimper

Kimmie Ng, MD, addressed the growing problem of early-onset gastrointestinal cancers in her keynote address at the ASCO GI Cancers Symposium. Screening has contributed to the declining incidence of colorectal cancer (CRC) in older individuals. However, CRC incidence has increased by 2% per year in those aged <50 years since the mid-1990s, particularly in non-Hispanic whites, and especially for rectal cancer.
The Lessons We Haven't Learned From COVID

Jan 29, 2024 | opmed.doximity.com | Amit Phull |Lynne Lederman |Hailey Roumimper

As we turn the page into a new year, a sense of renewal and opportunity usually pervades the air, but for me, the turning of the calendar page stirs a deep concern.
Promising New Combinations of Immunotherapies for GI Cancers

Jan 29, 2024 | opmed.doximity.com | Lynne Lederman |Amit Phull |Hailey Roumimper

Two late-breaking presentations at this year’s ASCO GI Cancers Symposium provided potentially practice-changing data on the addition of immunotherapy to standard-of-care (SOC) treatments for hepatocellular carcinoma (HCC) and metastatic colorectal cancer (mCRC) with unmet needs.